# Xinghuan Wang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/xinghuan-wang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 38,136 |
| Field | Urinary Bladder and Prostate Research |
| h-index | 74 |
| i10-index | 400 |
| Last Known Institution | Southern University of Science and Technology |
| OpenAlex ID | https://openalex.org/A5009012652 |
| ORCID iD | 0000-0003-3497-0024 |
| Works | 842 |

## Researcher papers

Showing 12 of 14.

- [Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)](https://scholariq.org/papers/cardiovascular-implications-of-fatal-outcomes-of-patients-with-coronavirus/)
- [A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)](https://scholariq.org/papers/a-rapid-advice-guideline-for-the-diagnosis-and-treatment-of-2019-novel/)
- [Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?](https://scholariq.org/papers/methodological-quality-risk-of-bias-assessment-tools-for-primary-and-secondary/)
- [Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial](https://scholariq.org/papers/immunogenicity-and-safety-of-a-recombinant-adenovirus-type-5-vectored-covid-19/)
- [Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19](https://scholariq.org/papers/association-of-inpatient-use-of-angiotensin-converting-enzyme-inhibitors-and/)
- [Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial](https://scholariq.org/papers/favipiravir-versus-arbidol-for-covid-19-a-randomized-clinical-trial/)
- [Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility](https://scholariq.org/papers/relationship-between-the-abo-blood-group-and-the-coronavirus-disease-2019-covid/)
- [Relationship between the ABO Blood Group and the COVID-19 Susceptibility](https://scholariq.org/papers/relationship-between-the-abo-blood-group-and-the-covid-19-susceptibility/)
- [AI-assisted CT imaging analysis for COVID-19 screening: Building and deploying a medical AI system](https://scholariq.org/papers/ai-assisted-ct-imaging-analysis-for-covid-19-screening-building-and-deploying-a/)
- [Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation](https://scholariq.org/papers/clinical-characteristics-of-severe-acute-respiratory-syndrome-coronavirus-2/)
- [Environmental contamination of SARS-CoV-2 in healthcare premises](https://scholariq.org/papers/environmental-contamination-of-sars-cov-2-in-healthcare-premises/)
- [Handheld laparoscopic robotized instrument: progress or challenge?](https://scholariq.org/papers/handheld-laparoscopic-robotized-instrument-progress-or-challenge/)

## Researcher topics

- [Urinary Bladder and Prostate Research](https://scholariq.org/topics/urinary-bladder-and-prostate-research/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)

## Researcher university

- [Southern University of Science and Technology](https://scholariq.org/institutions/southern-university-of-science-and-technology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.